Can valerian root be safely taken with my medications (amlodipine, valsartan, rosuvastatin, icosapent ethyl, repaglinide) and the supplement Sunargy, and what drug interactions or monitoring are required?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Valerian Root Drug Interactions with Your Medications

Valerian root can be safely taken with your current medications (amlodipine, valsartan, rosuvastatin, icosapent ethyl, and repaglinide) as there are no clinically significant interactions documented, though theoretical concerns exist with rosuvastatin that warrant monitoring.

Key Interaction Considerations

Rosuvastatin and Valerian Root

The primary theoretical concern involves valerian's potential effect on CYP3A4 metabolism. In vitro studies show valerian root extracts can inhibit CYP3A4 enzyme activity 1, which could theoretically increase statin exposure. However, rosuvastatin is minimally metabolized by CYP3A4 (unlike simvastatin or lovastatin), making this interaction clinically less relevant 2, 3.

Clinical evidence is reassuring: A well-designed human study found that 14 days of valerian (1000 mg nightly) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers 4. The study specifically tested alprazolam (a CYP3A4 substrate) and found only a modest, clinically insignificant increase in peak concentration.

Your Other Medications

Amlodipine: While amlodipine is a CYP3A4 substrate 2, the clinical study showing minimal CYP3A4 inhibition by valerian 4 suggests no significant interaction. Your combination of amlodipine with valsartan and rosuvastatin is well-studied and safe 5, 6.

Valsartan: No interaction expected. Valsartan is not significantly metabolized by CYP450 enzymes 7 and has been safely combined with rosuvastatin and amlodipine without issues 5.

Icosapent ethyl: No documented interactions with valerian. This purified EPA formulation has a distinct mechanism and is safely combined with statins 8.

Repaglinide: No documented interactions with valerian root.

Important Safety Considerations

Monitor for Sedation

The primary concern with valerian is additive sedative effects, not drug metabolism interactions. If you take any benzodiazepines, sedatives, or CNS depressants, valerian could enhance drowsiness 9. One case report documented significant sedation when valerian and passionflower were combined with lorazepam 9.

Muscle Symptom Monitoring

While taking rosuvastatin, remain vigilant for:

  • Unexplained muscle pain, tenderness, or weakness
  • Dark-colored urine
  • Unusual fatigue

These warrant immediate medical attention regardless of valerian use, as they could indicate statin-related myopathy 2, 3.

Clinical Recommendations

You may continue valerian root with your current medication regimen. The 2017 American Academy of Sleep Medicine guideline suggests valerian can be continued perioperatively due to its safety profile 10, and a 2021 perioperative guideline specifically states valerian may be continued and could protect against cognitive dysfunction 10.

Practical Monitoring

  • No specific lab monitoring is required for the valerian-medication combination beyond standard statin monitoring
  • Report any new muscle symptoms to your physician promptly
  • Avoid driving or operating machinery when first starting valerian to assess your individual sedation response
  • Use consistent valerian products, as quality varies significantly between commercial preparations 1

Product Quality Caveat

Research shows wide variation in valerenic acid content between commercial valerian products 1, 11, with actual content often differing from label claims. This variability affects both efficacy and potential interaction risk. Consider using pharmaceutical-grade or standardized extracts when possible.

Bottom Line

The combination is safe based on available evidence. The theoretical CYP3A4 interaction is not clinically significant for rosuvastatin, and human studies confirm minimal enzyme inhibition by valerian 4. Your primary consideration should be monitoring for excessive sedation rather than metabolic drug interactions 10.

References

Research

In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2004

Related Questions

Is there a drug interaction between tranexamic acid, losartan, empagliflozin, linagliptin, amlodipine, and atorvastatin?
In a 74-year-old man with hypertension and prediabetes, currently taking losartan 50 mg twice daily, amlodipine 10 mg nightly, and atorvastatin 20 mg nightly, who sustained a drill injury to the left ring finger 15 days ago and now has persistent distal‑phalangeal electric‑like pain with hypoesthesia, what is the recommended management?
In a 44-year-old patient with hypertension and dyslipidemia on losartan, amlodipine, atorvastatin, and omeprazole, who has 11 days of odynophagia, fever, productive cough, and new left otalgia after a 7‑day course of amoxicillin 500 mg every 8 hours without improvement, what is the most appropriate next therapeutic step?
Are there drug interactions between Adderall (mixed amphetamine salts) and amlodipine, losartan, ranolazine (Ranexa), rosuvastatin, and isosorbide?
In a 75-year-old patient with hypertension, type 2 diabetes, dyslipidemia, taking losartan, amlodipine, metformin, atorvastatin, and empagliflozin, and a known right‑eye pterygium, who presents with a 36‑hour history of a vague foreign‑body sensation in the eye without redness, visual changes, motility deficit, fever, edema, or discharge, and a normal fundus examination, what is the most likely diagnosis?
How long should oral loop diuretic therapy be continued for a patient with lower‑extremity edema due to heart failure?
What are the possible causes of eye pain with a sensation of a foreign body?
Can a patient taking Eliquis (apixaban) safely use valerian root to calm nerves?
When is Depo‑Medrol (methylprednisolone acetate) indicated for allergic rhinitis, and what are the recommended dosing and safety considerations?
What are the grades of umbilical hernia based on defect size and reducibility?
How should visual acuity be documented in a clinical record?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.